These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 453115)

  • 1. Computer-assisted heparin monitoring.
    Coe JM; Soloway HB
    Am J Clin Pathol; 1979 Jul; 72(1):74-6. PubMed ID: 453115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin monitoring during cardiopulmonary bypass.
    Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
    Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring heparin for anticoagulation during cardiopulmonary bypass].
    Li LH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Dec; 10(4):251-5. PubMed ID: 7160291
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a thrombin clotting time assay for measuring heparin activity.
    Penner JA
    Am J Clin Pathol; 1974 May; 61(5):645-53. PubMed ID: 4827049
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the Soviet-made microcomputer MK-54 for the calculation of heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Flërov KE
    Anesteziol Reanimatol; 1987; (3):57-9. PubMed ID: 3631636
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated clotting time for control of anticoagulation during surgery.
    Lefemine AA; Lewis M
    Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.